Catalyst Pharmaceuticals Inc (CPRX)
R&D Expense Growth
47.26%
Quarterly · Period ending:
CPRX R&D Expense Growth
Latest reported47.26%period ending
Latest reported47.26%period ending
CPRX Quarterly R&D Growth (QoQ) (0.00% → 47.26%)
Latest values, visible window
High-resolution chart · PNG
CPRX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 47.2607% | |
| -31.991% | |
| -39.0317% | |
| 12.1173% | |
| 2.3433% | |
| 15.6516% | |
| 10.0168% | |
| 15.6528% | |
| 30.8824% | |
| -97.6429% | |
| 2,015.8827% | |
| 11.0051% | |
| -12.9734% | |
| -50.7461% | |
| 108.6367% | |
| 17.0438% | |
| -31.8309% | |
| 11.2547% | |
| 0.8315% | |
| 47.988% | |
| -27.9765% | |
| 11.3638% | |
| -13.809% | |
| 2.9989% | |
| -33.0574% | |
| 37.2272% | |
| -0.6983% | |
| 39.9462% | |
| -60.6989% | |
| 85.4624% | |
| 22.4989% | |
| 13.6783% | |
| -4.2763% | |
| 25.8681% | |
| 10.3262% | |
| -12.8709% | |
| -0.2384% | |
| 13.0976% | |
| -0.5938% | |
| -29.2549% | |
| -7.4439% | |
| 25.9292% | |
| 18.047% | |
| 9.7021% | |
| -1.4549% | |
| -17.3829% | |
| 37.4917% | |
| -23.6377% | |
| 32.9097% | |
| -26.2545% | |
| 31.5339% | |
| 95.1878% | |
| 46.6782% | |
| 13.7217% | |
| 22.9185% | |
| -26.7536% | |
| -24.2557% | |
| 56.356% | |
| -32.1871% | |
| 0.1861% | |
| 58.8201% | |
| 13.8129% | |
| -37.3268% | |
| 81.5192% | |
| -19.7185% | |
| -35.6571% | |
| -38.1656% | |
| -40.746% | |
| -29.0227% | |
| 33.4796% | |
| 28.885% | |
| 75.4164% | |
| 50.1859% | |
| 43.4417% | |
| -49.8047% | |
| 31.5087% | |
| 137.6096% | |
| 36.2879% | |
| 8.82% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |